دورية أكاديمية

Ліпокалін, асоційований із желатиназою нейтрофілів (NGAL): функція, специфічність, роль у діагностиці ренальної дисфункції у хворих на артеріальну гіпертензію із супутніми ЦД 2-го типу й ожирінням.

التفاصيل البيبلوغرافية
العنوان: Ліпокалін, асоційований із желатиназою нейтрофілів (NGAL): функція, специфічність, роль у діагностиці ренальної дисфункції у хворих на артеріальну гіпертензію із супутніми ЦД 2-го типу й ожирінням. (Ukrainian)
العنوان البديل: Neutrophil gelatinase-associated lipocalin: function, specificity, role in the diagnosis of renal dysfunction in hypertensive patients with concomitant type 2 diabetes and obesity. (English)
المؤلفون: І. П., Дунаєва
المصدر: International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal; 2023, Vol. 19 Issue 5, p325-330, 6p
مصطلحات موضوعية: LIPOCALIN-2, DIASTOLIC blood pressure, SYSTOLIC blood pressure, ENZYME-linked immunosorbent assay, CYSTATIN C, ERGOCALCIFEROL, LIPOCALINS
مستخلص: Background. Neutrophil gelatinase-associated lipocalin (NGAL) belongs to the superfamily of lipocalins whose main function is the binding and transportation of hydrophobic molecules, siderophores, as the most important ligands of NGAL. The diagnostic significance of NGAL as a marker of renal dysfunction, as well as its prognostic value in terms of the further prognosis of the course of renal pathology has now been confirmed. The purpose of the study: to determine the role of NGAL in the development of renal dysfunction in hypertensive patients with comorbid type 2 diabetes (T2D) and obesity. Materials and methods. One hundred and eleven patients with hypertension (50 men, 61 women) aged 54.37 ± 1.18 years and 20 controls were examined. During the examination, they were divided into 4 groups depending on the presence of comorbid pathology: hypertension — the first group (n = 22); hypertension combined with obesity — the second group (n = 30); hypertension combined with T2D — the third group (n = 31); hypertension, T2D and obesity — the fourth group (n = 28). In all patients, body weight and height were measured, body mass index was calculated, levels of glycated hemoglobin, lipid metabolism, systolic and diastolic blood pressure were measured. The content of NGAL in blood serum was evaluated by the enzyme-linked immunosorbent assay. Results. The level of NGAL in all patients included in the study was significantly higher compared to the control group (p < 0.01). However, it was highest in comorbidity of hypertension, T2D and obesity, which, in turn, indicates a high risk of interstitial fibrosis in these patients. A significant correlation was found between the level of NGAL and the concentration of cardiotrophin (p < 0.032), catestatin (p < 0.001), β2-microglobulin (p < 0.001), cystatin (p < 0.021), atherogenic coefficient (p < 0.011), NT-proBNP (p < 0.014), vitamin D (p < 0.004). The obtained data demonstrate the significant role of NGAL in the development of early cardiovascular and renal complications in our patients. Conclusions. A significant increase in the level of NGAL was found in patients with hypertension, hypertension with T2D, hypertension with obesity, hypertension with T2DM and obesity compared to healthy individuals (p < 0.01). A significant correlation of the NGAL level with the serum concentration of cardiotrophin, catestatin, cystatin C, β2-microglobulin, atherogenic coefficient, NT-proBNP, and vitamin D in the examined patients was proved. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal is the property of Zaslavsky O.Yu and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:22240721
DOI:10.22141/2224-0721.19.5.2023.1294